Those who shorted this stock, tried to put the com

Those who shorted this stock, tried to put the company in financial difficulties, were unsuccessful in getting the company to take toxic financing but also succeeded in delaying the progress of the Bril-ABSSSI clinical trials and the Kevetrin trials -- yes, some of those people are very grateful that they were able to profit from shorting, and now have changed sides, have gone long, and are pumping.

The rest of us are not so happy with their tactic. But then, the rest of us are not the kind of scum who go on to message boards spewing lies for their own selfish financial gain, while people in need of medications die.